Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Tretinoin gel cleared for marketing by FDA

Feb. 11, 1997

Tsumura describes agents for dermatitis

Feb. 7, 1997

Hyal's Solarase submitted for approval

Feb. 5, 1997

Bone morphogenic protein-10 claimed by Human Genome Sciences

Feb. 5, 1997

Patent coverage sought for novel approach to reducing side effects of vitamin A

Feb. 4, 1997

Allergan continues research into retinoids and retinoid-like compounds

Feb. 3, 1997

Preclinical results support Pharmadigm's DHEA development program

Jan. 31, 1997

Pierre Fabre to market Penederm OTC product

Jan. 30, 1997

FDA clears Orphan Medical wound dressing

Jan. 30, 1997

Hair growth stimulants from Tanabe

Jan. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...